Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis
- PMID: 16212072
Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis
Abstract
Cardiovascular complications are the leading cause of death in diabetes. Over the past decade a number of studies have addressed the underlying mechanisms. Derangements of endothelial function, also referred to as endothelial dysfunction, have emerged to be the crucial early step in the development of atherosclerosis and are also involved in plaque progression and clinical emergence. Endothelial dysfunction is a condition of impaired endothelium-dependent vasodilation and most important of "endothelial activation", characterized by a proinflammatory, proliferative, and procoagulatory milieu that promotes initiation and complications of atherogenesis. A synergistic cross-talk among the conventional cardiovascular risk factors associated with diabetes contributes to disruption of endothelial integrity and accelerated atherosclerosis. This review will focus on the multifactorial nature of endothelial dysfunction in diabetes, the relationship between endothelial dysfunction, conventional cardiovascular risk factors and atherosclerosis, and the therapeutic options to improve endothelial function.
Similar articles
-
[Vascular complications in diabetes mellitus: role of endothelial dysfunction].Ned Tijdschr Geneeskd. 1996 Apr 20;140(16):870-4. Ned Tijdschr Geneeskd. 1996. PMID: 8692297 Review. Dutch. No abstract available.
-
Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.J Diabetes Complications. 2008 Jan-Feb;22(1):62-75. doi: 10.1016/j.jdiacomp.2006.10.009. J Diabetes Complications. 2008. PMID: 18191079 Review.
-
Insulin resistance and the endothelium.Am J Med. 2004 Jul 15;117(2):109-17. doi: 10.1016/j.amjmed.2004.02.042. Am J Med. 2004. PMID: 15234647 Review.
-
The proinflammatory and hypercoagulable state of diabetes mellitus.Rev Cardiovasc Med. 2005 Spring;6(2):84-97. Rev Cardiovasc Med. 2005. PMID: 15976731 Review.
-
[The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].Recenti Prog Med. 2005 Oct;96(10):499-507. Recenti Prog Med. 2005. PMID: 16491775 Review. Italian.
Cited by
-
CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.Blood Transfus. 2014 Apr;12(2):250-9. doi: 10.2450/2013.0101-13. Epub 2013 Nov 15. Blood Transfus. 2014. PMID: 24333075 Free PMC article.
-
Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats.Inflammopharmacology. 2013 Apr;21(2):137-45. doi: 10.1007/s10787-012-0154-4. Epub 2012 Oct 31. Inflammopharmacology. 2013. PMID: 23111552
-
Which inflammatory marker, between systemic immune-inflammation index and neutrophil to eosinophil ratio, is associated with Peyronie's disease and are there any implications for a better understanding of its mechanisms?Basic Clin Androl. 2023 Dec 19;33(1):38. doi: 10.1186/s12610-023-00213-y. Basic Clin Androl. 2023. PMID: 38110896 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous